file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 121, GCS 3531, CR 4288 Collection span: 1979 - 2009 | |
| Word(i) List (760) Word count: 2047, All words count: 2852 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 1 | PROSTATE | 91 | 68 | 1943 |
| 2 | CANCER | 73 | 60 | 1606 |
| 3 | CARCINOMA | 35 | 29 | 912 |
| 4 | PATIENTS | 20 | 21 | 677 |
| 5 | DETECTION | 17 | 18 | 595 |
| 6 | CELL | 22 | 15 | 509 |
| 7 | BLADDER | 31 | 25 | 481 |
| 8 | METASTATIC | 8 | 4 | 467 |
| 9 | RENAL | 14 | 4 | 390 |
| 10 | TRIAL | 11 | 6 | 350 |
| 11 | GROWTH | 12 | 2 | 341 |
| 12 | ENHANCED | 16 | 14 | 338 |
| 13 | PHASE | 8 | 3 | 336 |
| 14 | PLUS | 7 | 3 | 332 |
| 15 | HEMATOGENOUS | 2 | 8 | 329 |
| 16 | FACTOR | 9 | 2 | 322 |
| 17 | THERAPY | 24 | 17 | 320 |
| 18 | CELLS | 10 | 17 | 295 |
| 19 | MICROMETASTASIS | 1 | 7 | 292 |
| 20 | HORMONE | 3 | 1 | 286 |
| 21 | REFRACTORY | 3 | 1 | 286 |
| 22 | HUMAN | 7 | 0 | 282 |
| 23 | EXPRESSION | 3 | 3 | 260 |
| 24 | KIDNEY | 6 | 0 | 260 |
| 25 | ESTRAMUSTINE | 2 | 0 | 256 |
| 26 | PACLITAXEL | 2 | 0 | 256 |
| 27 | RADIATION | 15 | 13 | 248 |
| 28 | NORMAL | 5 | 1 | 238 |
| 29 | PROSTATECTOMY | 21 | 12 | 236 |
| 30 | ANTIGEN | 8 | 11 | 234 |
| # | Word | Recs | TLCS | TGCS |
| 31 | SPECIFIC | 8 | 11 | 234 |
| 32 | CHAIN | 3 | 6 | 205 |
| 33 | POLYMERASE | 3 | 6 | 205 |
| 34 | REACTION | 3 | 6 | 205 |
| 35 | CONTRAST | 18 | 14 | 198 |
| 36 | EFFECT | 12 | 11 | 197 |
| 37 | MEN | 6 | 3 | 197 |
| 38 | BETA | 4 | 2 | 192 |
| 39 | RADICAL | 15 | 8 | 192 |
| 40 | TRANSFORMING | 4 | 2 | 192 |
| 41 | HOUR | 1 | 0 | 190 |
| 42 | ORAL | 1 | 0 | 190 |
| 43 | PHOSPHATE | 1 | 0 | 190 |
| 44 | HIGH | 9 | 16 | 188 |
| 45 | ALPHA | 3 | 2 | 187 |
| 46 | GENE | 8 | 6 | 180 |
| 47 | LAPAROSCOPIC | 26 | 6 | 168 |
| 48 | TUMORS | 6 | 1 | 154 |
| 49 | IMAGING | 15 | 11 | 150 |
| 50 | ADULT | 1 | 0 | 142 |
| 51 | RISK | 5 | 4 | 142 |
| 52 | PELVIC | 2 | 1 | 140 |
| 53 | EARLY | 4 | 8 | 136 |
| 54 | ADJUVANT | 6 | 8 | 134 |
| 55 | SOLID | 4 | 1 | 130 |
| 56 | TECHNOLOGY | 3 | 1 | 130 |
| 57 | UTILIZATION | 2 | 1 | 130 |
| 58 | TUMOR | 9 | 1 | 129 |
| 59 | ASSESSMENT | 7 | 3 | 128 |
| 60 | DUTASTERIDE | 6 | 4 | 126 |
| # | Word | Recs | TLCS | TGCS |
| 61 | ANALYSIS | 14 | 5 | 125 |
| 62 | CIRCULATING | 3 | 3 | 120 |
| 63 | DOSE | 6 | 4 | 117 |
| 64 | MANAGEMENT | 6 | 9 | 117 |
| 65 | INTRAVESICAL | 5 | 4 | 115 |
| 66 | URINARY | 7 | 3 | 115 |
| 67 | PT3N0 | 3 | 5 | 114 |
| 68 | DOPPLER | 13 | 13 | 112 |
| 69 | TRANSITIONAL | 8 | 11 | 111 |
| 70 | LEVELS | 4 | 1 | 110 |
| 71 | CHEMOPREVENTION | 3 | 4 | 108 |
| 72 | EFFICACY | 4 | 5 | 108 |
| 73 | REDUCE | 4 | 4 | 108 |
| 74 | DISEASE | 4 | 9 | 107 |
| 75 | REVERSE | 2 | 6 | 105 |
| 76 | DESIGN | 2 | 3 | 104 |
| 77 | EVENTS | 3 | 3 | 104 |
| 78 | RATIONALE | 2 | 3 | 104 |
| 79 | REDUCTION | 3 | 3 | 104 |
| 80 | COMPARISON | 7 | 3 | 103 |
| 81 | APPROACHES | 5 | 0 | 99 |
| 82 | EPIDERMAL | 2 | 0 | 99 |
| 83 | MURINE | 3 | 3 | 99 |
| 84 | RECEPTOR | 2 | 0 | 99 |
| 85 | TREATMENT | 8 | 2 | 98 |
| 86 | SONOGRAPHY | 7 | 7 | 96 |
| 87 | SURVIVAL | 3 | 6 | 93 |
| 88 | IMMUNOTHERAPY | 2 | 2 | 91 |
| 89 | LAPAROSCOPY | 4 | 7 | 91 |
| 90 | BCG | 2 | 3 | 88 |
| # | Word | Recs | TLCS | TGCS |
| 91 | DEVELOPMENT | 4 | 4 | 88 |
| 92 | BIOCHEMICAL | 3 | 7 | 87 |
| 93 | CAPSULAR | 1 | 2 | 87 |
| 94 | COIL | 1 | 2 | 87 |
| 95 | CONTROL | 3 | 7 | 87 |
| 96 | CRITERIA | 1 | 2 | 87 |
| 97 | DIAGNOSTIC | 1 | 2 | 87 |
| 98 | ENDORECTAL | 1 | 2 | 87 |
| 99 | IMAGES | 1 | 2 | 87 |
| 100 | PENETRATION | 1 | 2 | 87 |